Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Acq. announced
Bionano Genomics, Inc. (BNGO) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/11/2023 8-K Quarterly results
10/11/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
08/17/2023 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
08/14/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Bionano Announces CFO Transition and Appointment of Gülsen Kama as Chief Financial Officer"
08/09/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/09/2023 8-K Quarterly results
Docs: "Bionano Reports Second Quarter 2023 Results and Highlights Recent Business Progress"
08/04/2023 8-K Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea...
Docs: "Certificate of Amendment to the Amended and Restated Certificate of Incorporation, as amended, of Bionano Genomics, Inc",
"Certificate of Elimination of Series A Preferred Stock"
07/07/2023 SC 13G/A BlackRock Inc. reports a 2% stake in Bionano Genomics, Inc
06/16/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/11/2023 EFFECT Form EFFECT - Notice of Effectiveness:
05/09/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/09/2023 8-K Quarterly results
Docs: "Bionano Reports First Quarter 2023 Results and Highlights Recent Business Progress"
05/08/2023 S-3/A Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
05/01/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/28/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/28/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/24/2023 8-K Quarterly results
04/14/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
04/14/2023 8-K Quarterly results
03/13/2023 8-K Other Events  Interactive Data
03/10/2023 S-3 Form S-3 - Registration statement under Securities Act of 1933:
03/09/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/09/2023 10-K Annual Report for the period ended December 31, 2022
03/09/2023 8-K Quarterly results
Docs: "Bionano Genomics Reports Fourth Quarter and Full Year 2022 Results and Provides Revenue Outlook for 2023"
03/09/2023 POSASR Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
02/03/2023 8-K Results of Operations and Financial Condition, Other Events  Interactive Data
01/30/2023 SC 13G/A BlackRock Inc. reports a 7.8% stake in Bionano Genomics, Inc
01/05/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Bionano Genomics Reports Preliminary Fourth Quarter and Full-Year 2022 Results - Preliminary Q4 revenue expected to be between $8.1 and $8.4 million; 29% to 33% increase over Q4 2021"
11/30/2022 8-K Quarterly results
11/29/2022 8-K Quarterly results
11/28/2022 8-K Quarterly results
11/18/2022 8-K Quarterly results
11/18/2022 CT ORDER Form CT ORDER - Confidential treatment order:
11/03/2022 10-Q Quarterly Report for the period ended September 30, 2022
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy